You have successfully sign out
Loading...
Isofol Medical AB (publ)
ISOFOL.ST
Company Description
Isofol Medical AB (publ), a clinical stage biotech company, develops, commercializes, and sells oncology drugs in Sweden and internationally. The company develops arfolitixorin, which is in phase 3 clinical trial for the treatment of advanced colorectal cancer. It has strategic collaborations with Recipharm, Merck & Cie, and Sahlgrenska University Hospital. The company was incorporated in 2008 and is headquartered in Gothenburg, Sweden.
Â
STO
Unprofitable
EPS improving
Unprofitable
EPS improving
1.00SEK
0.14Â ( 16.48%)Market Open
Relative Strenght
Volume Buzz
1113%
Earning Acce
No
Dist 52w H.
80%
